New Key Statistics Module, Z-Score and F-Score
AMEX:CCEL Key Ratios
| Market Cap $ M | 51.19 |
| Enterprise Value $ M | 63.54 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 36.08 |
| Forward PE Ratio | 48.85 |
| Price/Book | -- |
| Price/Sales | 1.67 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 31.00 |
| EPS (TTM) $ | -1.11 |
| Beneish M-Score | -2.55 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -266.10 |
| EV-to-EBIT | -5.40 |
| EV-to-EBITDA | -6.00 |
| PEG | -- |
| Shares Outstanding M | 8.06 |
| Net Margin (%) | -29.38 |
| Operating Margin % | 11.00 |
| Pre-tax Margin (%) | -40.00 |
| Quick Ratio | 0.49 |
| Current Ratio | 0.52 |
| ROA % (ttm) | -14.34 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | 3.74 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.54 |
CCEL Number of Guru Trades
CCEL Volume of Guru Trades
Gurus Latest Trades with AMEX:CCEL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:CCEL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cryo-Cell International Inc Insider Transactions
No Available Data
News about AMEX:CCEL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers